JP2002504520A5 - - Google Patents

Download PDF

Info

Publication number
JP2002504520A5
JP2002504520A5 JP2000533139A JP2000533139A JP2002504520A5 JP 2002504520 A5 JP2002504520 A5 JP 2002504520A5 JP 2000533139 A JP2000533139 A JP 2000533139A JP 2000533139 A JP2000533139 A JP 2000533139A JP 2002504520 A5 JP2002504520 A5 JP 2002504520A5
Authority
JP
Japan
Prior art keywords
kda
wound
active enamel
use according
amelogenin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000533139A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002504520A (ja
JP4726296B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB1999/000337 external-priority patent/WO1999043344A2/en
Publication of JP2002504520A publication Critical patent/JP2002504520A/ja
Publication of JP2002504520A5 publication Critical patent/JP2002504520A5/ja
Application granted granted Critical
Publication of JP4726296B2 publication Critical patent/JP4726296B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2000533139A 1998-02-27 1999-02-26 創傷治癒のためのマトリックスタンパク質組成物 Expired - Lifetime JP4726296B2 (ja)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
DK27098 1998-02-27
DK0270/98 1998-02-27
US8155198P 1998-04-13 1998-04-13
US60/081,551 1998-04-13
DK199800270 1998-07-21
DK199801328 1998-10-16
DK60/081,551 1998-10-16
DKPA199801328 1998-10-16
DKPA199801328 1998-10-16
PCT/IB1999/000337 WO1999043344A2 (en) 1998-02-27 1999-02-26 Matrix protein compositions for wound healing

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2007131100A Division JP5024866B2 (ja) 1998-02-27 2007-05-17 創傷治癒のためのマトリックスタンパク質組成物

Publications (3)

Publication Number Publication Date
JP2002504520A JP2002504520A (ja) 2002-02-12
JP2002504520A5 true JP2002504520A5 (https=) 2005-07-21
JP4726296B2 JP4726296B2 (ja) 2011-07-20

Family

ID=34395112

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000533139A Expired - Lifetime JP4726296B2 (ja) 1998-02-27 1999-02-26 創傷治癒のためのマトリックスタンパク質組成物

Country Status (6)

Country Link
US (3) US6503539B2 (https=)
JP (1) JP4726296B2 (https=)
AR (1) AR020055A1 (https=)
BR (1) BRPI9908182C1 (https=)
PL (1) PL204797B1 (https=)
RU (1) RU2241489C2 (https=)

Families Citing this family (87)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2640994C (en) * 1998-02-27 2013-07-09 Biora Bioex Ab Enamel matrix protein composition for preventing or treating infection
US6884427B1 (en) * 1999-02-08 2005-04-26 Aderans Research Institute, Inc. Filamentary means for introducing agents into tissue of a living host
US20030096740A1 (en) * 1999-03-10 2003-05-22 Lars Hammarstrom Matrix protein compositions for induction of apoptosis
US6979670B1 (en) * 1999-03-10 2005-12-27 Biora Bioex Ab Matrix protein compositions for grafting
ATE285821T1 (de) * 1999-10-08 2005-01-15 Affinium Pharm Inc Fab i inhibitoren
US6821953B1 (en) * 1999-12-16 2004-11-23 University Of Southern California Methods for treating and preventing damage to mucosal tissue
DE60140191D1 (de) * 2000-06-20 2009-11-26 Straumann Inst Ag Zusammensetzungen mit matrixproteinen zur regeneration von dentin
US7304030B2 (en) * 2000-06-20 2007-12-04 Biora Ab Matrix protein composition for dentin regeneration
EP1309361A1 (en) * 2000-08-08 2003-05-14 Bioamide, Inc. Scaffolds for tissue engineered hair
US7144729B2 (en) 2000-09-01 2006-12-05 Dfb Pharmaceuticals, Inc. Methods and compositions for tissue regeneration
US20040018228A1 (en) * 2000-11-06 2004-01-29 Afmedica, Inc. Compositions and methods for reducing scar tissue formation
CA2434254C (en) * 2001-01-12 2013-08-13 Board Of Regents, The University Of Texas System Novel antiseptic derivatives with broad spectrum antimicrobial activity for the impregnation of surfaces
US7033611B2 (en) * 2001-02-23 2006-04-25 Biora Bioex Ab Matrix protein compositions for guided connective tissue growth
CA2444597A1 (en) * 2001-04-06 2002-10-06 Affinium Pharmaceuticals, Inc. Fab i inhibitors
PL369029A1 (en) * 2001-09-14 2005-04-18 Biora Bioex Ab Enamel matrix protein compositions for modulating immune response
EP1467673A4 (en) * 2002-01-23 2013-04-17 Dentsply Int Inc Irrigation solution and methods for use
US20040068284A1 (en) * 2002-01-29 2004-04-08 Barrows Thomas H. Method for stimulating hair growth and kit for carrying out said method
JP4948744B2 (ja) * 2002-10-04 2012-06-06 允 深江 歯周組織再生剤、その有効成分抽出法、およびプラスミド
EP1575951B1 (en) 2002-12-06 2014-06-25 Debiopharm International SA Heterocyclic compounds, methods of making them and their use in therapy
JP2004307454A (ja) * 2003-02-21 2004-11-04 Seikagaku Kogyo Co Ltd 生理活性ペプチド及びこれを含有する薬剤
US7494980B2 (en) * 2003-03-10 2009-02-24 The United States Of America As Represented By The Secretary Of The Army Antimicrobial peptide and methods of use thereof
US8778889B2 (en) * 2003-03-10 2014-07-15 The United States Of America As Represented By The Secretary Of The Army Antimicrobial decapeptide oral hygiene treatment
DE602004016831D1 (de) * 2003-03-17 2008-11-13 Affinium Pharm Inc Pharmazeutische zusammensetzungen inhibitoren von fab i und weitere antibiotika enthaltend
SI1644024T1 (sl) * 2003-06-06 2019-11-29 Univ Texas Protimikrobne raztopine za izpiranje
EP1641783B1 (en) * 2003-06-19 2012-03-28 Janssen Pharmaceutica NV Aminosulfonyl substituted 4-(aminomethyl)-piperidine benzamides as 5ht4-antagonists
CA2576040A1 (en) * 2003-10-21 2005-04-28 Bioartificial Gel Technologies Inc. Hydrogel-containing medical articles and methods of using and making the same
US20050125033A1 (en) * 2003-12-04 2005-06-09 Mcnally-Heintzelman Karen M. Wound closure apparatus
US20050125015A1 (en) * 2003-12-04 2005-06-09 Mcnally-Heintzelman Karen M. Tissue-handling apparatus, system and method
CA2552911A1 (en) * 2004-01-20 2005-08-11 Board Of Regents, The University Of Texas System Methods for coating and impregnating medical devices with antiseptic compositions
US7597885B2 (en) * 2004-03-26 2009-10-06 Aderans Research Institute, Inc. Tissue engineered biomimetic hair follicle graft
US20050220821A1 (en) * 2004-03-31 2005-10-06 Allergan, Inc. Pressure sore treatment
EP2848614A3 (en) 2004-06-04 2015-07-29 Debiopharm International SA Acrylamide derivatives as antibiotic agents
AR050212A1 (es) * 2004-08-13 2006-10-04 Aderans Res Inst Inc Organogenesis a partir de celulas disociadas
RU2277933C2 (ru) * 2004-09-21 2006-06-20 Государственное образовательное учреждение высшего профессионального образования Курский государственный медицинский университет Министерства здравоохранения Российской Федерации Иммобилизованная форма цефазолина для профилактики послеоперационных инфекционных осложнений в оториноларингологии
US20060115782A1 (en) * 2004-11-30 2006-06-01 Chunhua Li Systems and methods for coating a dental appliance
US7766658B2 (en) * 2004-11-30 2010-08-03 Align Technology, Inc. Systems and methods for intra-oral diagnosis
US20060115785A1 (en) 2004-11-30 2006-06-01 Chunhua Li Systems and methods for intra-oral drug delivery
US7947508B2 (en) * 2004-11-30 2011-05-24 Align Technology, Inc. Systems and methods for intra-oral diagnosis
AU2005315253B2 (en) * 2004-12-10 2011-07-21 Straumann Holding Ag Protein formulation
SE0403014D0 (sv) * 2004-12-10 2004-12-10 Straumann Holding Ag New protein formulation
WO2006126096A2 (en) * 2005-04-09 2006-11-30 Makoto Fukae Effect of porcinesheath proteins on the regeneration activity of periodontal ligament
US20070048358A1 (en) * 2005-08-31 2007-03-01 Schorr Phillip A Antimicrobial substrates
US20070048356A1 (en) * 2005-08-31 2007-03-01 Schorr Phillip A Antimicrobial treatment of nonwoven materials for infection control
US20070048344A1 (en) * 2005-08-31 2007-03-01 Ali Yahiaoui Antimicrobial composition
US20070048345A1 (en) * 2005-08-31 2007-03-01 Kimberly-Clark Worldwide, Inc. Antimicrobial composition
WO2007062306A2 (en) 2005-11-18 2007-05-31 The Board Of Regents Of The University Of Texas System Methods for coating surfaces with antimicrobial agents
AR057628A1 (es) * 2005-11-22 2007-12-05 Aderans Res Inst Inc Injertos capilares derivados de cabello extirpado
US20070148138A1 (en) * 2005-11-22 2007-06-28 Aderans Research Institute, Inc. Hair follicle graft from tissue engineered skin
EP1973902A2 (en) * 2005-12-05 2008-10-01 Affinium Pharmaceuticals, Inc. 3-heterocyclylacrylamide compounds as fabi inhibitors and antibacterial agents
US20070135706A1 (en) * 2005-12-13 2007-06-14 Shimko Daniel A Debridement method, device and kit
US20070148187A1 (en) * 2005-12-27 2007-06-28 Intact Enterprises, Inc. Mastic gum composition for use as a dietary supplement in humans and animals
WO2008006083A2 (en) * 2006-07-07 2008-01-10 Surmodics, Inc. Beaded wound spacer device
EP2687533B1 (en) 2006-07-20 2017-07-19 Debiopharm International SA Acrylamide derivatives as FAB I inhibitors
US7772213B2 (en) * 2006-07-27 2010-08-10 Nathan Strick Composition for the treatment of inflammatory conditions
US8623842B2 (en) * 2006-09-27 2014-01-07 Hemostasis, Llc Hemostatic agent and method
WO2008098374A1 (en) 2007-02-16 2008-08-21 Affinium Pharmaceuticals, Inc. Salts, prodrugs and polymorphs of fab i inhibitors
EP2120561A4 (en) 2007-02-19 2012-11-21 Plurogen Therapeutics Inc COMPOSITIONS FOR TREATING BIOFILMS, AND METHODS FOR THEIR USE
US7985537B2 (en) * 2007-06-12 2011-07-26 Aderans Research Institute, Inc. Methods for determining the hair follicle inductive properties of a composition
US20090202609A1 (en) * 2008-01-06 2009-08-13 Keough Steven J Medical device with coating composition
JP2012526840A (ja) * 2009-05-13 2012-11-01 プロテイン デリヴァリー ソリューションズ エルエルシー 膜貫通送達のための製剤系
WO2010135449A1 (en) * 2009-05-19 2010-11-25 Plurogen Therapeutics, Inc. Surface active agent compositions and methods for enhancing oxygenation, reducing bacteria and improving wound healing
US9192626B2 (en) * 2009-06-10 2015-11-24 American Silver, Llc Dental uses of silver hydrosol
CN101991688A (zh) * 2009-08-20 2011-03-30 徐荣祥 药物组合物在制备治疗糖尿病溃疡药物中的用途
US8790613B2 (en) * 2010-02-24 2014-07-29 Erachem Comilog, Inc. Treated electrolytic manganese dioxide and method for its production
CA2801332C (en) 2010-10-15 2016-08-23 Straumann Holding Ag New emd formulation comprising pga
BR112013030381B1 (pt) 2011-05-27 2021-10-26 University Of Washington Through Its Center For Commercialization Produto de cuidado oral
SI2861608T1 (sl) 2012-06-19 2019-08-30 Debiopharm International Sa Derivati predzdravila (E)-N-metil-N-((3-metilbenzofuran-2-IL)metil)- 3-(7-okso-5,6,7,8-tetrahidro-1 ,8-nafthiridin-3-il)akrilamid
US20140023979A1 (en) * 2012-07-18 2014-01-23 Maha Mohamed Fouad Mounir Regeneration of ameloblast cells and dental enamel in vivo
WO2014062839A1 (en) 2012-10-16 2014-04-24 Surmodics, Inc. Wound packing device and methods
US20140186273A1 (en) * 2012-12-27 2014-07-03 University Of Southern California Chitosan -Amelogenin Hydrogel for In Situ Enamel Growth
US20140272803A1 (en) * 2013-03-14 2014-09-18 Alan Nevins Root canal for tissue in-growth
EP3001810B1 (en) * 2013-04-30 2020-03-11 Straumann Holding AG Trap 63
JP6483139B2 (ja) * 2014-01-17 2019-03-13 ストラウマン ホールディング アーゲー 増強した安定性のemdの製造方法
US10201457B2 (en) 2014-08-01 2019-02-12 Surmodics, Inc. Wound packing device with nanotextured surface
US9238090B1 (en) 2014-12-24 2016-01-19 Fettech, Llc Tissue-based compositions
WO2016118644A1 (en) 2015-01-20 2016-07-28 Plurogen Therapeutics, Llc Compositions and methods of treating microbes
US9962465B2 (en) 2015-07-07 2018-05-08 University Of Southern California Amelogenin-chitosan hydrogel for dentin hypersensitivity
WO2017123986A1 (en) 2016-01-13 2017-07-20 University Of Washington Reagents and methods for mineralization of tooth enamel
JP6952353B2 (ja) 2016-01-31 2021-10-20 メディウーンド リミテッド 創傷を治療するためのデブリードマン組成物
BR122023021456A2 (pt) 2016-02-26 2024-02-20 Debiopharm International S.A. Uso de di-hidrogeno fosfato de {6- [(e)-3-{metil[(3-metil-1-benfofuran-2- iol)metil]amino)-3- oxopro-1-en-1-il]-2-oxo-3,4-di-hidro-1,8-naftiridin-1(2h)- il}metila para tratamento de osteomielite do pé diabético e composição farmacêutica
BR112018071405A2 (pt) * 2016-04-18 2019-02-05 Mediwound Ltd métodos de debridamento de ferimentos crônicos
LT3923914T (lt) 2019-02-14 2023-07-25 Debiopharm International S.A. Afabicino kompozicija, jos gamybos būdas
CN113939306B (zh) 2019-06-14 2024-07-19 德彪药业国际股份公司 用于治疗涉及生物膜的细菌感染的药物及其用途
US11457996B2 (en) * 2019-09-12 2022-10-04 King Abdulaziz University Dental pulp capping composition and method of preserving and regenerating capped pulp and dentin bridge
CZ308980B6 (cs) 2020-01-24 2021-11-03 Contipro A.S. Dentální přípravek z vláken na bázi kyseliny hyaluronové s regulovatelnou biodegradabilitou
US20240269167A1 (en) * 2020-12-21 2024-08-15 Biointelligent Technology Systems Slu A mucosal re-epithelialization composition
KR102802100B1 (ko) * 2023-07-14 2025-05-02 주식회사 티앤알바이오팹 흡수성 체내 지혈 키트 및 흡수성 체내 지혈제

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU98529A1 (ru) * 1952-04-04 1953-11-30 Конструкторское Бюро Особое Рабочее колесо центробежного погружного насоса
SU1398869A1 (ru) * 1985-10-31 1988-05-30 Московский медицинский стоматологический институт им.Н.А.Семашко Способ лечени зв желудка и двенадцатиперстной кишки
SE454480B (sv) 1986-09-25 1988-05-09 Lars Hammarstrom Bindningsinducerande komposition
SE461313B (sv) 1988-03-17 1990-02-05 Biora Ab Bindningsinducerande komposition
SE503096C2 (sv) 1994-09-22 1996-03-25 Biora Ab Komposition innehållande EDTA för användning vid konditionering av tandrötter
EP0837880B1 (en) 1995-07-13 2005-08-17 Biora Ab Enamel matrix related polypeptide

Similar Documents

Publication Publication Date Title
JP2002504520A5 (https=)
RU2000124523A (ru) Композиции матриксных протеинов для залечивания ран
CA2322215A1 (en) Matrix protein compositions for wound healing
US7294352B2 (en) Matrix protein composition for treating inflammation
JP2007291115A5 (https=)
JP2927850B2 (ja) 歯とその支持組織の症状の治療のための局所用製剤
JP2007291115A6 (ja) 創傷治癒のためのマトリックスタンパク質組成物
US4789662A (en) Method for the treatment of periodontal pockets with a composition comprising collagen and an antiseptic or anti-inflammatory substance
JP2004501063A5 (https=)
JPH09503504A (ja) 成人歯周炎の治療のためのアジトロマイシンの用途とこの用途のための局所組成物
FR3035790A3 (fr) Preparation dentaire a base d'hyaluronane et de dichlorhydrate d'octenidine
JP3582537B2 (ja) 口腔用組成物
CN106581060B (zh) 一种加强型牙龈修复和口腔护理的组合物及其应用
JPH06211636A (ja) 口腔用組成物
KR102372384B1 (ko) 치주질환 및 구취 예방 또는 개선용 구강 위생 조성물
RU2229872C1 (ru) Средство местного действия, оказывающее стимулирующее влияние на процессы восстановления клеток
HK1030880B (en) Matrix protein compositions for wound healing
CZ20002986A3 (cs) Prostředky na bázi proteinů matrice pro hojení ran
Surendran et al. Innovations in Wound Dressings
MXPA00008240A (en) Matrix protein compositions for wound healing